Dong Woo Song

This inventor holds 9 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Toolgen Inc., Seoul National University, Aavatar Therapeutics CO.,LTD.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Woo Song. Retrieved from https://idiyas.com/inventor/dong-woo-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 15)

Average Co-Inventor Count = 4.5

ph-index = 1

Company Filing History:

Seoul National University

patents

1 out of 1

Aavatar Therapeutics CO.,LTD.

patent

4. 1 out of 99

Institute for Basic Science

patents

where one patent can have more than one assignee

Years Active: 2023-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12642256 - HEMOPHILIA B RAT MODEL (2026-06-02),

2. 12486521 - PLATFORM FOR EXPRESSING PROTEIN OF INTEREST IN LIVER (2025-12-02),

3. 12480098 - ADENO-ASSOCIATED VIRUS VARIANT (2025-11-25),

4. 12331086 - Artificially engineered SC function control system (2025-06-17),

5. 12163149 - Artificial genome manipulation for gene expression regulation (2024-12-10),

6. 11999952 - Artificially-manipulated neovascularization regulatory system (2024-06-04),

7. 11845951 - Gene manipulation for treatment of retinal dysfunction disorder (2023-12-19),

8. 11667934 - Platform for expressing protein of interest in liver (2023-06-06),

9. 11572574 - Artificial genome manipulation for gene expression regulation (2023-02-07),

Title: The Innovations of Dong Woo Song

Introduction

Dong Woo Song is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of gene expression and control systems. With a total of six patents to his name, his work has the potential to impact various medical applications.

Latest Patents

One of his latest patents is titled "Artificially Engineered SC Function Control System." This invention relates to an artificially manipulated SC function-controlling factor aimed at controlling SC function and treating diseases associated with SC function disorders. The system includes an artificially manipulated SC function-controlling factor and a composition for alleviating diseases caused by SC function disorders. Another notable patent is "Artificial Genome Manipulation for Gene Expression Regulation." This invention focuses on an expression control composition designed to regulate the expression of duplicate genes and offers methods for treating diseases caused by gene duplication.

Career Highlights

Dong Woo Song has worked with notable organizations such as Toolgen Inc. and Seoul National University. His experience in these institutions has allowed him to develop innovative solutions in biotechnology and gene manipulation.

Collaborations

Throughout his career, Dong Woo Song has collaborated with talented individuals, including Jung Min Lee and Seokjoong Kim. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Dong Woo Song's contributions to biotechnology through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical treatments and gene regulation.

Profile summary based on public USPTO records.